Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Review

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

       
Total article views   HTML views PDF downloads Totals
12,247 Dovepress* 11,085+ 1,464 12,549
PubMed Central* 1,162 328 1,490
Totals 12,247 1,792 14,039
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar